LDS/Medical Tests/Bordetella pertussis Antibody, IgA, IgG

Bordetella pertussis Antibody, IgA, IgG

Bordetella pertussis is the causative bacteria of pertussis (Whooping Cough). Bordetella pertussis belongs to a fastidious group of gram-negative aerobic coccobacilli. Transmission occurs through direct contact with secretions from respiratory mucous membranes of an infected person. The incubation period of pertussis is usually 7-10 days after exposure but may range from 2-3 weeks. Infection with B. pertussis can cause severe disease in very young children who are non-immunized. It begins with mild upper respiratory tract symptoms and progresses to cough, which then can further progress to severe paroxysms, often with a characteristic inspiratory whoop followed by vomiting. Pneumonia is the most common complication and cause of pertussis-related deaths. Young infants are at highest risk for pertussis-related complications, including seizures, encephalopathy, and otitis media.

For many years vaccine against whooping cough has been used to drastically reduce the number of cases in children and infants who would otherwise die of whooping cough. Of late, pertussis cases have been reported in the immunized adolescent age group and therefore pertussis booster immunizations are now recommended to prevent additional public health risks. Bordetella serology testing can detect antibodies of IgG, IgA, and IgM classes. IgG antibodies to B. pertussis can be detected in the blood of vaccinated patients (confirming immune status), newborns of vaccinated mothers due to transfer of antibody across the placenta, and in patients who have recently been infected with the bacteria but are now recovering. IgG presence alone is not a conclusive test for active infection. Paired titers exhibiting increase in concentration can be used to confirm an active immune response, but timing of specimen collection to capture IgG peaks can be complicated. IgA and IgM antibody levels are a more conclusive test to diagnose active disease.

  • Differential diagnosis of acute infection with *Bordetella pertussis
  • Evaluation of immunity following vaccination

Increased in:

  • Whooping cough
  • Vaccination to B. pertussis

Bordetella serology tests should be used as a screening test for immune status. It should not be used as a sole test for diagnostic use. Positive antibody levels are reflexed to Western Blot (Immunoblot) or PCR assay for confirmatory testing.

Negative in non-immunized and never-infected individuals. Positive in immunized or previously infected..
 

 

Microhemagglutination, Complement fixation, Toxin Neutralization, Enzyme Linked Immunosorbent Assay

Serum (SST).

Stability

  • Ambient: 3-5 days
  • Refrigerated: 7-14 days
  • Frozen: 30 days
Nasopharynx Culture for *B. pertussis, B. pertussis* by DFA, *B. pertussis* by PCR, Sputum Culture, *Bordetella pertussis* Culture.
1-8 days.
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
Please log in to view content.
Create an account to get a 30-day free trial.
Login
  • Adv Ther. 2007 Mar-Apr;24(2):353-61. [PMID: 17565926]
  • Crit Rev Microbiol. 2012 May; 38(2):111-21. [PMID: 22103249]
  • J Clin Microbiol. 2005 Oct;43(10):4925-9. [PMID: 16207944]
  • Eur J Clin Microbiol Infect Dis. 2000 Feb;19(2):77-88. [PMID: 10746492]
  • Jacobs, David S., DeMott, Wayne R., (2001). Laboratory Test Handbook. 5th. Hudson, OH. Lexi-Comp, Inc.